Answers are grounded in this paper and cite their sources.
Immunization of mice by the intranasal route with influenza virus hemagglutinin in combination with the mutant Escherichia coli heat-labile enterotoxin R72 (LT-R72) induced significantly enhanced serum and mucosal antibodies, surpassing, in most cases, responses achieved by traditional intramuscular immunization using inactivated split influenza vaccine. Furthermore, intranasal immunization with LT-R72 induced a potent serum immunoglobulin G2a response, indicating that this adjuvant has Th1 character.
No takes yet. Share an insight, caveat, or question.
Barackman et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: